Chengdu Haoneng Tech Co Ltd

Haoneng Shares announced on October 9 that it plans to sign a joint venture contract with FAW Qixin Power Changchun Technology Co., Ltd. to jointly invest 70 million yuan in establishing a joint venture company. Haoneng Shares will subscribe 23.1 million yuan in cash, holding a 33% stake in the joint venture. The investment aims to deepen the company's layout in the new energy vehicle parts business and expand sales channels for automotive parts such as coaxial reducers. In the first half of 2026, Haoneng Shares achieved revenue of 1.495 billion yuan and net profit attributable to the parent company of 188 million yuan.

GigaDevice chairman Zhu Yiming has proposed a 1 to 2 billion yuan buyback of the company's A-shares, with all repurchased shares to be cancelled and registered capital reduced. Zhu also pledged not to reduce his holdings in the next 12 months and plans to increase his stake by no less than 1 billion yuan between 13 December 2026 and 29 July 2027. Hengrui Medicine's self-developed Shudi insulin injection, China's first long-acting insulin analogue, has been approved for marketing to treat adult type 2 diabetes. Xingyun Technology's wholly owned subsidiary Shenzhen Xingyun signed a supplementary agreement with a VB client, increasing the number of computing power service units from 128 to 256, with the total tax-inclusive amount adjusted from 1.014 billion yuan to 3.053 billion yuan, a 201.14% increase over the original contract. Yitian Intelligent's wholly owned subsidiary Gansu Yisuan signed a 1.106 billion yuan computing power resource service contract with client Y Company, with a service period of 60 months, representing over 100% of the company's audited main business revenue for the most recent fiscal year. Haoneng Technology plans to invest 1 billion yuan to build a production base for robot joint reducers, with an annual capacity of 5 million units upon completion. A consortium led by United Science and Technology won the bid for the CBTC signalling system localisation retrofit project for Shenyang Metro Line 2, with a contract value of 243 million yuan.

On the evening of July 29, multiple listed companies on the Shanghai and Shenzhen exchanges released significant positive announcements. Tinavi Medical Technologies plans to acquire a 62% equity stake in Shanghai Minimally Invasive Orthopedic Medical Technology through a share issuance, along with raising supporting funds. Upon completion of the deal, the company will complete its orthopedic implant product portfolio, and its shares will resume trading on July 30. Haoneng Corporation plans to invest 1 billion yuan to build a production base for robot joint reducers in Luzhou, with an annual capacity of 5 million units upon completion. Western Mining disclosed its semi-annual report, with operating revenue reaching 39.443 billion yuan in the first half of 2026, up 25% year-on-year, and net profit attributable to shareholders of the listed company reaching 4.169 billion yuan, up 123% year-on-year. Yitian Intelligent's wholly-owned subsidiary Gansu Yisuan signed a computing power resource service contract worth 1.106 billion yuan, with the tax-inclusive contract amount exceeding 100% of the company's audited main business revenue for the most recent fiscal year. The chairman of GigaDevice proposed a share buyback of 1 billion to 2 billion yuan for cancellation, and also plans to increase his shareholding in the company by no less than 1 billion yuan. Yongding Corporation's holding subsidiary Suzhou Dingxin Optoelectronics Technology has received purchase orders for high-power laser chips totaling approximately 1.133 billion yuan over the past month. In addition, Lead Intelligent's foldable screen chip-level polymer 3D printing equipment has achieved mass delivery and production verification, Midea Group's air conditioning dual bases added 200,000 units in European orders within one month, Hengxing New Materials plans to invest approximately 600 million yuan to launch two fine chemical new material projects, and Tianhe Magnetics plans to establish a holding subsidiary to address service gaps in the southern market.

Haoneng Shares announced that its wholly-owned subsidiary, Chongqing Haoneng Transmission Technology Company Limited, has completed industrial and commercial registration for a capital increase, raising its registered capital from 270 million yuan to 770 million yuan. The company's board of directors approved the use of 500 million yuan in raised funds to increase capital in Chongqing Haoneng on June 25, 2026, and it remains a wholly-owned subsidiary after the increase. Chongqing Haoneng's legal representative remains Fu Ping, and its business scope covers the manufacturing of automotive parts and components, motorcycle parts and components, as well as the manufacturing and sale of gears and gearboxes.